GRCE insider trading — Grace Therapeutics, Inc.
Over the last 90 days, insiders at Grace Therapeutics, Inc. (GRCE) made 16 open-market purchases worth $608K and 0 open-market sales worth $0, making them net buyers by $608K. The largest purchase was by Kohli Prashant (Chief Executive Officer), who bought 100,000 shares for $214K on Sep 9, 2026. 2 different insiders bought shares in this period — a cluster buy, which many investors watch closely.
Updated Oct 16, 2026.
Recent GRCE insider transactions
Every Form 4 filed by Grace Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 36,347 | $1.89 | $69K | Form 4 |
| Oct 15, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 23,485 | $1.95 | $46K | Form 4 |
| Oct 14, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 11,233 | $1.93 | $22K | Form 4 |
| Oct 12, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 7,215 | $2.02 | $15K | Form 4 |
| Oct 9, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 5,340 | $2.04 | $11K | Form 4 |
| Oct 8, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 2,077 | $2.02 | $4K | Form 4 |
| Oct 5, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 1,694 | $2.06 | $3K | Form 4 |
| Oct 2, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 20,000 | $2.07 | $41K | Form 4 |
| Oct 1, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 38,796 | $2.04 | $79K | Form 4 |
| Sep 29, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 7,849 | $2.09 | $16K | Form 4 |
| Sep 23, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 5,318 | $2.10 | $11K | Form 4 |
| Sep 21, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 9,771 | $2.10 | $21K | Form 4 |
| Sep 9, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 5,836 | $2.09 | $12K | Form 4 |
| Sep 8, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 9,393 | $2.10 | $20K | Form 4 |
| Sep 9, 2026 | Kohli Prashant | Chief Executive Officer | P · Purchase | Direct | 100,000 | $2.14 | $214K | Form 4 |
| Aug 14, 2026 | Opaleye Management Inc. | 10% Owner | P · Purchase | Indirect | 11,608 | $2.09 | $24K | Form 4 |
GRCE insider trading FAQ
Are insiders buying GRCE stock?
Yes. In the last 90 days, Grace Therapeutics, Inc. insiders made 16 open-market purchases totaling $608K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading GRCE?
Recent buyers: Kohli Prashant, Opaleye Management Inc..
Where does GRCE insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.